Lantheus to Present at the Morgan Stanley Annual Global Healthcare Conference
Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH) is a prominent company specializing in radiopharmaceuticals. Their mission is to empower clinicians in the fight against disease and to improve patient outcomes. The company is pleased to announce that Brian Markison, the Chief Executive Officer, will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference. This presentation is set for 7:45 a.m. ET on a Wednesday in September.
How to Access the Presentation
If you are interested in watching the live presentation, you can do so via a webcast. To participate, please visit the Investors section of the Company’s website at www.lantheus.com. Once the live event is over, a recording will be available on the company’s website for at least 30 days, allowing those who missed it to catch up on the valuable insights shared.
About Lantheus Holdings, Inc.
Lantheus is a trailblazer in the realm of radiopharmaceuticals, dedicated to providing transformative scientific solutions for disease detection and treatment. For more than 65 years, the company has focused on delivering innovative radiopharmaceutical products that assist healthcare professionals in their vital roles. With its headquarters in Massachusetts and additional offices in Canada and Sweden, Lantheus is continually working to enhance its contributions to the healthcare industry.
Leadership and Strategic Initiatives
Guided by Brian Markison and a committed team, Lantheus is dedicated to harnessing scientific progress to support clinicians. The company’s mission centers on improving patient outcomes by ensuring healthcare providers have access to the most effective tools and technologies for disease management. This dedication is evident in their ongoing research and collaboration with healthcare partners to broaden their product range.
Strategic Goals and Developments
Lantheus consistently seeks opportunities to enhance its service offerings. By investing in research and development, the company aims to create innovative solutions that meet the changing needs of healthcare professionals and patients. The upcoming presentation at the Morgan Stanley Conference is just one of many initiatives that reflect Lantheus’s commitment to excellence in healthcare.
Engaging with Stakeholders
In its efforts to connect with stakeholders, Lantheus emphasizes transparency and open communication. The forthcoming presentation is anticipated to provide valuable insights into the company’s strategic direction and technological innovations. By keeping stakeholders informed, Lantheus strengthens its relationships and reaffirms its commitment to enhancing patient care.
Contact Information
If you have any questions regarding the presentation or other company-related matters, please reach out to:
Mark Kinarney
Vice President, Investor Relations
Telephone: 978-671-8842
Email: ir@lantheus.com
Melissa Downs
Senior Director, External Communications
Telephone: 646-975-2533
Email: media@lantheus.com
Frequently Asked Questions
What is the significance of Lantheus attending the Global Healthcare Conference?
Lantheus's participation underscores its dedication to sharing advancements in radiopharmaceuticals and enhancing patient care.
When will Brian Markison present at the conference?
Brian Markison will be presenting at 7:45 a.m. ET on a Wednesday in September.
How can I access the webcast of the presentation?
You can access the webcast through the Investors section of the Lantheus website at www.lantheus.com.
What is the focus of Lantheus as a company?
Lantheus is committed to enabling clinicians to Find, Fight, and Follow disease through innovative radiopharmaceutical solutions.
Who can I contact for more information about Lantheus?
For more information, you can reach out to Mark Kinarney or Melissa Downs using the contact details provided.
